RCEL250117C22500
- 0.00
- 0.000.00%
Avita Medical Newsroom
Further Weakness as AVITA Medical (NASDAQ:RCEL) Drops 30% This Week, Taking Five-year Losses to 83%
Avita Medical Target Cut by 4.4% to A$4.36/Share by Morgans
Avita Medical Shares Are Trading Lower After Lake Street Cut Its Price Target on the Stock From $20 to $14.
Avita Medical Cuts Annual Sales Forecast On Softer Demand From Hospitals
Lake Street Maintains Buy on AVITA Medical, Lowers Price Target to $14
AVITA Medical Shares Slump on Lowered Outlook
AVITA Medical, Quantum Computing And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Express News | D. Boral Capital Maintains Buy on AVITA Medical, Maintains $25 Price Target
AVITA Medical Analyst Ratings
Top Premarket Decliners
Australian Shares Rise as November Inflation Data Signals Easing Potential; Avita Medical Lowers Revenue Guidance
BTIG Maintains Avita Medical(RCEL.US) With Hold Rating
Avita Medical (RCEL) Receives a Hold From BTIG
Avita Medical Cuts Q4, 2024 Commercial Revenue Outlook -- Shares Fall After Hours
AVITA Medical: Several Hospital Accounts Adjusted Inventory Levels at End of FY, Resulting in Less Purchasing >RCEL
AVITA Medical Cites Slower-than-expected Purchasing Activity
AVITA Medical Cuts 4Q View To Commercial Rev $18.4M >RCEL
Press Release: AVITA Medical Updates Expected Fourth Quarter and Full Year 2024 Revenue, Provides 2025 Financial Guidance
Express News | AVITA Medical Updates Expected Fourth Quarter and Full Year 2024 Revenue, Provides 2025 Financial Guidance
Express News | AVITA Medical Outlook FY Commercial Revenue USD 100-106 Million